3,840
Views
72
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Number of patients potentially eligible for proton therapy

, , , , , , & show all
Pages 836-849 | Received 23 Aug 2005, Published online: 08 Jul 2009

References

  • Hellman S. Technology, biology and traffic. Acta Oncol 2001; 40: 679–81
  • Mattsson S, Brahme A, Carlsson J, Denekamp J, Forsell-Aronsson E, Hellström M, et al. Swedish Cancer Society radiation therapy research investigation. Acta Oncol 2002; 41: 596–603
  • World Health Organization. www.who.int/mediacentre/news/releases/2003/pr27/en.
  • Norlund A. Costs of radiotherapy. Acta Oncol 2003; 42: 411–5
  • Yuh GE, Loredo LN, Yonemoto LT, Bush DA, Shahnazi K, Preston W, et al. Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer J 2004; 10: 386–90
  • Bentzen SM. High-tech in radiation oncology: should there be a ceiling?. Int J Radiat Oncol Biol Phys 2004; 58: 320–30
  • Johansson KA, Mattsson S, Brahme A, Carlsson J, Zackrisson B, Turesson I, et al. Radiation therapy dose delivery. Acta Oncol 2003; 42: 85–91
  • Turesson I, Johansson K-A, Mattsson M. The potential of proton and light ion beams in radiotherapy. Acta Oncol 2003; 42: 107–14
  • Glimelius B, Steineck G. Low evidence of radiation therapy in prostate cancer-a plea for intensified scientific activity. Acta Oncol 2004; 43: 311–5
  • Bentzen SM. From clincal trials to clinical practice: A user's guide to evidence-based oncology. Eur J Cancer Suppl 2003; 1: 77–91
  • Sisterson J. World-wide charged particle patient totals. July 2005. Particles 2005; 33: 11
  • Egger E, Zografos L, Schalenbourg A, Beati D, Bohringer T, Chamot L, et al. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 2003; 55: 867–80
  • Noel G, Habrand JL, Mammar H, Pontvert D, Haie-Meder C, Hasboun D, et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protontherapie D'Orsay experience. Int J Radiat Oncol Biol Phys 2001; 51: 392–8
  • Suit H, Goldberg S, Niemierko A, Trofimov A, Adams J, Paganetti H, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol 2003; 42: 800–8
  • Goodman C. Literature searching and evidence interpretation for assessing health care practices. Swedish Council on Technology Assessment in Health Care. Norstedts, Stockholm 1993; 81
  • Ringborg U, Bergqvist D, Brorsson B, Cavallin-Ståhl E, Ceberg J, Einhorn N, et al. The Swedish Council on technology assessment in health care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden – 2001 summary and conclusions. Acta Oncol 2003; 42: 357–65
  • Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys 2003; 55: 51–63
  • Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer. Int J Radiat Oncol Biol Phys 2003; 56: 1295–307
  • Foroudi F, Tyldesley S, Walker H, Mackillop WJ. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys 2002; 53: 1240–53
  • Tyldesley S, Boyd C, Schulze K, Walker H, Mackillop WJ. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys 2001; 49: 973–85
  • Nilsson S, Widmark A, Norlén BJ. A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 2004; 43: 316–81
  • Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol 2003; 42: 443–61
  • Ask A, Albertsson M, Järhult J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in oesophageal cancer. Acta Oncol 2003; 42: 462–75
  • Glimelius B, Grönberg H, Järhult J, Wallgren A, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003; 42: 476–92
  • Sirzén F, Kjellen E, Sörenson S, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in non-small cell lung cancer. Acta Oncol 2003; 42: 493–515
  • Strander H, Turesson I, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol 2003; 42: 516–31
  • Rutqvist LE, Rose C, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in breast cancer. Acta Oncol 2003; 42: 532–45
  • Einhorn N, Trope C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in uterine cancer (corpus uteri). Acta Oncol 2003; 42: 557–61
  • Einhorn N, Trope C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in ovarian cancer. Acta Oncol 2003; 42: 562–6
  • Einhorn N, Trope C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in cervical cancer (cervix uteri). Acta Oncol 2003; 42: 546–56
  • Widmark A, Flodgren P, Damber J, Hellsten S, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in urinary bladder cancer. Acta Oncol 2003; 42: 567–81
  • Berg G, Blomquist E, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in brain tumours. Acta Oncol 2003; 42: 582–8
  • Gustavsson A, Osterman B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma. Acta Oncol 2003; 42: 605–19
  • Gustavsson A, Osterman B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in Hodgkin's lymphoma. Acta Oncol 2003; 42: 589–604
  • Falkmer U, Järhult J, Wersäll P, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol 2003; 42: 620–33
  • Bentzen SM, Heeren G, Cottier B, Slotman B, Glimelius B, Lievens Y, et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 2005; 75: 355–65
  • Möller TR, Brorsson B, Ceberg J, Frodin JE, Lindholm C, Nylen U, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 2003; 42: 387–410
  • Lundkvist J, Ekman M, Rehn Ericsson S, Isacsson U, Jönsson B, Glimelius B. Economic evaluation of proton radiation therapy in the treatment of breast cancer. Radiother Oncol 2005; 75: 179–85
  • Lundkvist J, Ekman M, Rehn Ericsson S, Jönsson B, Glimelius B. Proton therapy of cancer: Potential clinical advantages and cost-effectiveness. Acta Oncol 2005; 44:850–61.
  • Lundkvist J, Ekman M, Rehn Ericsson S, Jönsson B, Glimelius B. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 2005; 103: 793–801
  • Lievens Y, Van den Bogaert W. Proton beam therapy: too expensive to become true?. Radiother Oncol 2005; 75: 131–3
  • Orrecchia R, Krengli M. Number of potential patients to be treated with proton therapy in Italy. Tumori 1998; 84: 205–8
  • Krengli M, Orecchia R. Medical aspects of the National Centre for Oncological Hadrontherapy (CNAO-Centro Nazionale Adroterapia Oncologica) in Italy. Radiother Oncol 2004; 73(Suppl 2)21–8
  • Baron MH, Pommier P, Favrel V, Truc G, Balosso J, Rochat J. A “one-day survey”: As a reliable estimation of the potential recruitment for proton- and carbon-ion therapy in France. Radiother Oncol 2004; 73(Suppl 2)15–7
  • Mayer R, Mock U, Jäger R, Pötter R, Vutuc C, Eiter H, et al. Epidemiological aspects of hadron therapy: A prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO). Radiother Oncol 2004; 73(Suppl 2)24–8
  • Svensson H, Möller T. Developments in radiotherapy. Acta Oncol 2003; 42: 430–42
  • Glimelius B, Isacsson U, Blomquist E, Grusell E, Jung B, Montelius A. Potential gains using high-energy protons for therapy of malignant tumours. Acta Oncol 1999; 38: 137–45
  • Zackrisson B, Mattsson S, Kjellén E, Glimelius B, Swedish Cancer Society Investigation Group. Research and development of radiation therapy in clinical routines. Acta Oncol 2003; 42: 115–22
  • Turesson I, Carlsson J, Brahme A, Glimelius B, Zackrisson B, Stenerlow B, et al. Biological response to radiation therapy. Acta Oncol 2003; 42: 92–106
  • Proceedings of the heavy charged particles in Biology and Medicine (HCPBM) and ENLIGHT meetings in Baden and Lyon. Amaldi U, Auberger T, Debus J, Francois G, Gerard JP, Heeren G, et al editors Radiother Oncol 2004;73, (Suppl 2):S1–S217.
  • Haberer T, Debus J, Eickhoff H, Jakel O, Schulz-Ertner D, Weber U. The Heidelberg Ion Therapy Center. Radiother Oncol 2004; 73(Suppl 2)S186–90
  • Weyrather WK, Debus J. Particle beams for cancer therapy. Clin Oncol (R Coll Radiol) 2003; 15: S23–8
  • Griesmayer E, Auberger T. The status of MedAustron. Radiother Oncol 2004; 73(Suppl 2)S202–5
  • Amaldi U. CNAO–The Italian Centre for Light-Ion Therapy. Radiother Oncol 2004; 73(Suppl 2)S191–201
  • Bajard M, De Conto JM, Remillieux J. Status of the “ETOILE” project for a French hadrontherapy centre. Radiother Oncol 2004; 73(Suppl 2)S211–5
  • Forssell-Aronsson E, Kjellén E, Mattsson S, Hellström M, Swedish Cancer Society Investigation Group. Medical imaging for improved tumour characterisation, delineation and treatment verification. Acta Oncol 2002; 41: 604–14
  • Gregoire V. Is there any future in radiotherapy planning without the use of PET: unraveling the myth. Radiother Oncol 2004; 73: 261–3
  • Facey K, Bradbury I, Laking G, Payne E. Positron Emission Tomography (PET) in Cancer Management. Health Technology Assessment, NHS R&D HTA Programme July 2004.
  • Suit HD, Becht J, Leong J, Stracher M, Wood WC, Verhey L, et al. Potential for improvement in radiation therapy. Int J Radiat Oncol Biol Phys 1988; 14: 777–86
  • Brown AP, Urie MM, Chisin R, Suit HD. Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning. Int J Radiat Oncol Biol Phys 1989; 16: 1607–14
  • Urie MM, Goitein M. Variable versus fixed modulation of proton beams for treatments in the cranium. Med Phys 1989; 16: 593–601
  • Austin-Seymour M, Urie M, Munzenrider J. Considerations in fractionated proton radiation therapy: clinical potential and results. Radiother Oncol 1990; 17: 29–35
  • Tatsuzaki H, Urie MM, Willett CG. 3-D comparative study of proton vs. x-ray radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 1992; 22: 369–74
  • Archambeau JO, Slater JD, Slater JM, Tangeman R. Role for proton-beam irradiation in treatment of peciatric CNS malignancies. Int J Radiat Oncol Biol Phys 1992; 22: 287–94
  • Gademann G, Wannenmacher M. Charged particle therapy to pediatric tumors of the retroperitoneal region: a possible indication. Int J Radiat Oncol Biol Phys 1992; 22: 375–81
  • Levin CV. Potential for gain in the use of proton-beam boost to the para-aortic lymph nodes in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1992; 22: 355–60
  • Miralbell R, Crowell C, Suit HD. Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int J Radiat Oncol Biol Phys 1992; 22: 305–10
  • Slater JM, Slater JD, Archambeau JO. Carcinoma of the tonsillar region: potential for use of proton-beam therapy. Int J Radiat Oncol Biol Phys 1992; 22: 311–9
  • Smit B. Prospects for proton therapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1992; 22: 349–54
  • Tatsuzaki H, Gregoire V, Linggood R. Comparative treatment planning: proton vs x-ray beams against glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1992; 22: 265–74
  • Wambersie A, Gregroire V, Brucher JM. Potential clinical gain of proton (and heavy ion) beams for brain tumors in children. Int J Radiat Oncol Biol Phys 1992; 22: 275–86
  • Miralbell R, Urie M. Potential improvement of three dimension treatment planning and proton beams in fractionated radiotherapy of large cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys 1993; 25: 353–8
  • Lee M, Wynne C, Webb S, Nahum AE, Dearnaley D. A comparison of proton and megavoltage X-ray treatment planning for prostate cancer. Radiother Oncol 1994; 33: 239–53
  • Isacsson U, Montelius A, Jung B, Glimelius B. Comparative treatment planning between proton and x-ray therapy in locally advanced rectal cancer. Radiother Oncol 1996; 41: 263–72
  • Isacsson U, Hagberg H, Johansson KA, Montelius A, Jung B, Glimelius B. Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiother Oncol 1997; 45: 63–70
  • Miralbell R, Lomax A, Bortfeld T, Rouzaud M, Carrie C. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume. Int J Radiat Oncol Biol Phys 1997; 38: 477–84
  • Miralbell R, Lomax A, Russo M. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation. Int J Radiat Oncol Biol Phys 1997; 38: 805–11
  • Sandison GA, Papiez E, Bloch C, Morphis J. Phantom assessment of lung dose from proton arc therapy. Int J Radiat Oncol Biol Phys 1997; 38: 891–7
  • Isacsson U, Lennernäs B, Grusell E, Jung B, Montelius A, Glimelius B. Comparative treatment planning between proton and x-ray therapy in esophageal cancer. Int J Radiat Oncol Biol Phys 1998; 41: 441–50
  • Verhey LJ, Smith V, Serago CF. Comparison of radiosurgery treatment modalities based on physical dose distributions. Int J Radiat Oncol Biol Phys 1998; 40: 497–505
  • Fuss M, Hug EB, Schaefer RA, Nevinny-Stickel M, Miller DW, Slater JM, et al. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Phys 1999; 45: 1117–26
  • Lee C, Tait D, Nahum A, Webb S. Comparison of proton therapy and conformal x-ray therapy in non-small cell lung cancer (NSCLC). Br J Radiat 1999; 72: 1078–84
  • Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol 1999; 44: 185–205
  • Lomax AJ, Bortfeld T, Goitein G, Debus J, Dykstra C, Tercier PA, et al. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol 1999; 51: 257–71
  • Fuss M, Poljanc K, Miller DW, Archambeau JO, Slater JM, Slater JD, et al. Normal tissue complication probability (NTCP) calculations as a means to compare proton and photon plans and evaluation of clinical appropriateness of calculated values. Int J Cancer 2000; 90: 351–8
  • Lin R, Hug EB, Schaefer RA, Miller DW, Slater JM, Slater JD. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. Int J Radiat Oncol Biol Phys 2000; 48: 1219–26
  • Miralbell R, Cella L, Weber D, Lomax A. Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams. Int J Radiat Oncol Biol Phys 2000; 47: 1111–9
  • Oelfke U, Bortfeld T. Intensity modulated radiotherapy with charged particle beams: studies of inverse treatment planning for rotation therapy. Med Phys 2000; 27: 1246–57
  • Paulino AC, Wen BC, Brown CK, Tannous R, Mayr NA, Zhen WK, et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys 2000; 46: 1239–46
  • Smith AR, Loeffler JS, Adams JA, Lomax AJ, Niemierko A. The potential for proton therapy to improve clinical outcomes: Comparisons of proton and x-ray treatment plans for the purpose of tumor dose escalation and/or reduction of treatment-related morbidity. Int J Radiat Oncol Biol Phys 2000;48, (Suppl 338 abstr 2150).
  • Zurlo A, Lomax A, Hoess A, Bortfeld T, Russo M, Goitein G, et al. The role of proton therapy in the treatment of large irradiation volumes: a comparative planning study of pancreatic and biliary tumors. Int J Radiat Oncol Biol Phys 2000; 48: 277–88
  • Baumert BG, Lomax AJ, Miltchev V, Davis JB. A comparison of dose distributions of proton and photon beams in stereotactic conformal radiotherapy of brain lesions. Int J Radiat Oncol Biol Phys 2001; 49: 1439–49
  • Cella L, Lomax A, Miralbell R. Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2001; 49: 217–23
  • Cozzi L, Fogliata A, Lomax A, Bolsi A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 2001; 61: 287–97
  • Johansson J, Isacsson U, Lindman H, Montelius A, Glimelius B. Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques. Radiother Oncol 2002; 65: 89–98
  • Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002; 54: 824–9
  • Bolsi A, Fogliata A, Cozzi L. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study. Radiother Oncol 2003; 68: 1–14
  • Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 2003; 55: 785–92
  • Lomax AJ, Goitein M, Adams J. Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus. Radiother Oncol 2003; 66: 11–8
  • Johansson J, Blomquist E, Montelius A, Isacsson U, Glimelius B. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma. Radiother Oncol 2004; 72: 129–38
  • Mock U, Georg D, Bogner J, Auberger T, Potter R. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004; 58: 147–54
  • St Clair WH, Adams JA, Bues M, Fullerton BC, La Shell S, Kooy HM, et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004; 58: 727–34
  • Weber DC, Trofimov AV, Delaney TF, Bortfeld T. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys 2004; 58: 1596–606
  • Yock TI, Tarbell NJ. Technology insight: proton beam radiotherapy for treatment in pediatric brain tumours. Review. Nat Clin Pract Oncol 2004; 1: 97–103
  • Krengli M, Hug EB, Adams JA, Smith AR, Tarbell NJ, Munzenrider JE. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements. Int J Radiat Oncol Biol Phys 2005; 61: 583–93
  • Mu X, Björk-Eriksson T, Nill S, Oelfke U, Johansson K-A, Gagliardi G, et al. Does electron and proton therapy reduce the risk for late-effects after spinal irradiation for childhood medulloblastoma?-A comparative treatment planning study. Acta Oncol 2005; 44: 554–62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.